No CDC Level 4 “Avoid All Travel” notices are active as of early June 2026, with the agency’s official notices page confirming zero entries at that threshold. Recent health alerts remain at Level 1 or 2 for dengue across 16 countries and polio circulation in parts of Africa and Asia, while Ebola monitoring in the Democratic Republic of the Congo has prompted enhanced screening but not a Level 4 designation. These contained outbreaks and lower-tier precautions reflect current epidemiological data showing no extreme, unmitigable global health risks meeting the criteria for a highest-level notice before year-end. Trader consensus at 76.5% against issuance aligns with the absence of rapid escalation signals in official surveillance.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоCDC выпустит предупреждение 4-го уровня до 31 декабря?
Да
$71,851 Объем
$71,851 Объем
Да
$71,851 Объем
$71,851 Объем
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Открытие рынка: Jan 19, 2026, 3:15 PM ET
Resolver
0x65070BE91...A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...No CDC Level 4 “Avoid All Travel” notices are active as of early June 2026, with the agency’s official notices page confirming zero entries at that threshold. Recent health alerts remain at Level 1 or 2 for dengue across 16 countries and polio circulation in parts of Africa and Asia, while Ebola monitoring in the Democratic Republic of the Congo has prompted enhanced screening but not a Level 4 designation. These contained outbreaks and lower-tier precautions reflect current epidemiological data showing no extreme, unmitigable global health risks meeting the criteria for a highest-level notice before year-end. Trader consensus at 76.5% against issuance aligns with the absence of rapid escalation signals in official surveillance.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы